Key references: Introduction to novel psychoactive substance poisoning

  • Cairns R, Brown JA, Gunja N, Buckley NA. The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre. Int J Drug Policy 2017;43:74-82. https://www.ncbi.nlm.nih.gov/pubmed/28343112
  • Dargan PI, Wood DM, editors. Novel psychoactive substances: classification, pharmacology and toxicology. London: Acadmic Press; 2013.
  • Davey Z, Schifano F, Corazza O, Deluca P, Psychonaut Web Mapping Group. e-Psychonauts: conducting research in online drug forum communities. J Ment Health 2012;21(4):386–94. https://www.ncbi.nlm.nih.gov/pubmed/22823094
  • Gibbons S. 'Legal highs'--novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clin Toxicol (Phila) 2012;50(1):15–24. https://www.ncbi.nlm.nih.gov/pubmed/22248120
  • Glennon RA. Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention. Adv Pharmacol. 2014;69:581–620. https://www.ncbi.nlm.nih.gov/pubmed/24484988
  • Hill SL, Thomas SH. Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila) 2011;49(8):705–19. https://www.ncbi.nlm.nih.gov/pubmed/21970769
  • Tracy DK, Wood DM, Baumeister D. Novel psychoactive substances: types, mechanisms of action, and effects. BMJ 2017;356:i6848. https://www.ncbi.nlm.nih.gov/pubmed/28122697